Skip to content

Effect of Exercise on Hepatic Fat in Overweight Children

The Effect of Exercise on Hepatic Fat in Overweight Children; the EFIGRO Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02258126
Acronym
EFIGRO
Enrollment
115
Registered
2014-10-07
Start date
2014-11-30
Completion date
2018-01-31
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Non-alcoholic Fatty Liver Disease, Obesity

Keywords

overweight children, hepatic fat, exercise, nutritional education program, cardiometabolic risk

Brief summary

The objective of the present study is to evaluate the effect of 6 months exercise intervention program on hepatic fat fraction in overweight children. Methodology: A total of 160 children, 9-11 years old, will be randomly assigned to control (N=80) or intervention (N=80) groups. Training sessions will include 90 minutes of exercise, comprising warm-up and skill development. The control group will attend a healthy lifestyle education program (2 days/month) and the intervention group an exercise (3 days/week) and healthy lifestyle education (2 days/month) combined program. Before and after the intervention (6 months) hepatic fat fraction, body composition, , and cardiometabolic risk factors will be measured. Furthermore, dietary habits and physical activity, blood pressure and pubertal development will be evaluated before and after the intervention.

Detailed description

The control group will attend a healthy lifestyle education program (2 days/month) and supportive therapy and behavioral advice for both children and parents to improve nutrition and physical activity (nutritionists and psychologists). The intervention group will attend an exercise (3 days/week) and healthy lifestyle education (2 days/month) combined program. Training sessions will include 90 minutes of exercise, comprising warm-up and skill development, moderate to vigorous aerobic activities, flexibility and strength exercises. Before (baseline) and after the intervention (6 months) total and abdominal adiposity, lean tissue mass and bone mass density (dual-X-ray-absorptiometry), abdominal visceral and hepatic adiposity (magnetic resonance imaging), and blood insulin, glucose, C-reactive protein, alanine aminotransferase, aspartate aminotransferase, gamma-glutamil transpeptidase and lipid profile will be measured. Furthermore, cardiorespiratory fitness (treadmill test) and blood pressure will be measured before and after the intervention. Changes (6 months - baseline) in dietary habits will be estimated by using two repeated 24h recalls and food frequency questionnaires and changes (6 months - baseline) in physical activity by accelerometry.

Interventions

Exercise group: The intervention program includes an education program promoting healthy dietary habits and physical activity (nutritionist), supportive therapy and behavioral advice for the family to improve nutrition and physical activity (psychologist) (2 times/month, for children and parents) and supervised exercise (3 times/week, 90 mins) program for 6 months.

Sponsors

University of the Basque Country (UPV/EHU)
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* Overweight or obesity status * 9-11 years old

Exclusion criteria

* Medical conditions that hamper their participation in the exercise program * Secondary obesity

Design outcomes

Primary

MeasureTime frameDescription
changes in hepatic fatbaseline and 6 monthsChanges in hepatic fat fraction measured by magnetic resonance imaging after the 6 months intervention program

Secondary

MeasureTime frameDescription
Changes in serum lipid profilebaseline and 6 monthsChanges in total, LDL- and HDL-cholesterol after the 6 months intervention program
Changes in liver enzymesbaseline and 6 monthsChanges in total, alanine transaminase (ALT), aspartate transaminase (AST) and gamma-GT after the 6 months intervention program
Changes in dietary habitsbaseline and 6 monthsChanges in dietary habits estimated by 24h recall and food frequency questionnaire after the 6 months intervention program
Changes in Insulin sensitivitybaseline and 6 monthsChanges in insulin sensitivu¡ity measured by homeostasis model assessment (HOMA) after the 6 months intervention program
Changes in body compositionbaseline and 6 monthsChanges in visceral adipose tissue (MRI), abdominal and total adiposity (DEXA), lean tissue mass and bone mass (DEXA) the 6 months intervention program
Changes in other cardiometabolic risk factorsbaseline and 6 monthsChanges in blood pressure, leptin, adiponectin, C-reactive protein (CRP) after the 6 months intervention program
Changes in physical activitybaseline and 6 monthsChanges in physical activity estimated by accelerometry after the 6 months intervention program

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026